- Home
- TRST vs CDXC Comparison
TRST vs CDXC Comparison
Compare TRST & CDXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRST
- CDXC
- Stock Information
- Founded
- TRST 1902
- CDXC 1999
- Country
- TRST United States
- CDXC United States
- Employees
- TRST N/A
- CDXC N/A
- Industry
- TRST Major Banks
- CDXC Medicinal Chemicals and Botanical Products
- Sector
- TRST Finance
- CDXC Health Care
- Exchange
- TRST Nasdaq
- CDXC Nasdaq
- Market Cap
- TRST 627.3M
- CDXC 546.9M
- IPO Year
- TRST N/A
- CDXC N/A
- Fundamental
- Price
- TRST $36.77
- CDXC $7.63
- Analyst Decision
- TRST
- CDXC Strong Buy
- Analyst Count
- TRST 0
- CDXC 2
- Target Price
- TRST N/A
- CDXC $8.00
- AVG Volume (30 Days)
- TRST 78.3K
- CDXC 3.0M
- Earning Date
- TRST 10-21-2024
- CDXC 10-31-2024
- Dividend Yield
- TRST 3.90%
- CDXC N/A
- EPS Growth
- TRST N/A
- CDXC N/A
- EPS
- TRST 2.48
- CDXC 0.02
- Revenue
- TRST $168,593,000.00
- CDXC $91,668,000.00
- Revenue This Year
- TRST N/A
- CDXC $18.64
- Revenue Next Year
- TRST $11.69
- CDXC $20.72
- P/E Ratio
- TRST $14.63
- CDXC $388.80
- Revenue Growth
- TRST N/A
- CDXC 9.95
- 52 Week Low
- TRST $25.83
- CDXC $1.32
- 52 Week High
- TRST $37.84
- CDXC $7.85
- Technical
- Relative Strength Index (RSI)
- TRST 62.66
- CDXC 75.32
- Support Level
- TRST $35.79
- CDXC $6.80
- Resistance Level
- TRST $37.74
- CDXC $7.67
- Average True Range (ATR)
- TRST 1.01
- CDXC 0.58
- MACD
- TRST 0.05
- CDXC 0.07
- Stochastic Oscillator
- TRST 81.03
- CDXC 91.16
About TRST TrustCo Bank Corp NY
Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The Company based on only one business segment, that of community banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey and Vermont.
About CDXC ChromaDex Corporation
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.